Total synthesis of dolabellane diterpenoid claenone

Tetrahedron Letters

Volumn 39, Issue 36, 1998, Pages 6503-6506

  Miyaoka, Hiroaki ^a   Isaji, Yutaka ^a   Kajiwara, Yasuhiro ^a   Kunimune, Iyo ^a   Yamada, Yasuji ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Antitumour compounds; Marine metabolites; Michael reaction; Natural products; Terpens and terpenoids

Indexed keywords

CLAENONE; DITERPENOID; DOLABELLANE DERIVATIVE; MANNITOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHIRALITY; CYCLIZATION; DRUG ISOLATION; DRUG SYNTHESIS; METHYLATION; NONHUMAN; REACTION ANALYSIS;

EID: 0032171337     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01385-9     Document Type: Article

References (29)

1. [1] a) Faulkner DJ. Nat. Prod. Rep. 1998;15:113-158, and previous paper in this series.
2. b) For recent original literature on dolabellane diterpenoid and references cited therein: Durán R, Zubía E, Ortega MJ, Salvá J. Tetrahedron 1997;53:8675-8688.
3. [2] a) Bowden BF, Braeekman J-C, Coll JC, Mitchell SJ. Aust. J. Chem. 1980;33:927-932.
4. b) Asakawa Y, Lin X, Tori M, Kondo K. Phytochemistry 1990;29:2597-2603.
5. [3] Mori K, Iguchi K, Yamada N, Yamada Y, Inouye Y. Chem. Pharm. Bull. 1988;36:2840-2652.
6. [4] The cytotoxic activity was measured by National Cancer Institute, USA.
7. [5] Total synthesis of dolabellane diterpenoid: a) Corey EJ, Kania RS. Tetrahedron Lett. 1998;39:741-744.
8. b) Corey EJ, Kania RS. J. Am. Chem. Soc. 1996;118:1229-1230.
9. c) Jenny L, Borschberg H-J. Helv. Chim. Acta 1995;78:715-731.
10. d) Williams DR, Coleman PJ. Tetrahedron Lett. 1995;36:35-38.
11. [6] Synthetic studies for dolabellane diterpenoid: a) Luker T, Whitby RJ. Tetrahedron Lett. 1996;37:7661-7664.
12. b) Mehta G, Karra SR, Krishnamurthy N. Tetrahedron Lett. 1994;35:2761-2762.
13. c) Kato N, Higo A, Nakanishi K, Wu X, Takeshita H. Chem. Lett. 1994:1967-1970.
14. d) Williams DR, Coleman PJ, Nevill CR, Robinson LA. Tetrahedron Lett. 1993;34:7895-7898.
15. e) Williams DR, Coleman PJ, Henry SS. J. Am. Chem. Soc. 1993;115:11654-11655.
16. [7] a) Miyaoka H, Saka Y, Miura S, Yamada Y. Tetrahedron Lett. 1996;37:7107-7110.
17. b) Nagaoka H, Shibuya K, Yamada Y. Tetrahedron Lett. 1993;34:1501-1504.
18. c) Iwashima M, Nagaoka H, Kobayashi K, Yamada Y. Tetrahedron Lett. 1992;33:81-82.
19. d) Nagaoka H, Kobayashi K, Yamada Y. Tetrahedron Lett. 1988;29:5945-5946.
20. [8] Numbering of compounds is in accordance with that for claenone.
21. [9] Leonard J, Mohialdin S, Swain PA. Synthe. Commun. 1989; 19:3529-3534.
22. 2Cl, r.t., 53%.
23. 4, 0°C,
24. [12] Hwu JR, Wetzel JM. J. Org. Chem. 1985;50:3946-3948.
25. [13] Trost BM, Curran DP. Tetrahedron Lett. 1981;22:1287-1290.
26. 2, 0°C, 80%.
27. [15] Cheng Y-S, Liu W-L, Chen S. Synthesis 1980:223-224.
28. [16] Gao Y, Hanson RM, Klunder JM, Ko SY, Masamune H, Sharpless KB. J. Am. Chem. Soc. 1987;109:5765-5780 and references cited therein.
29. [17] Dauben WG, Michno DM. J. Org. Chem. 1977;42:682-685.